Recall archive / FDA drug enforcement

Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of P... — FDA record D-0872-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 22, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Reason: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Classification: Class II
Recalling firm: Pfizer Inc.
Quantity: 2079 bottles
Agency-reported status: Terminated
Source record identifier: D-0872-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot: DR9639 Exp. MAR 31 2023

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Nationwide and Puerto Rico

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: May 25, 2022
Recall initiation date: Apr 22, 2022
Center classification date: May 16, 2022
Termination date: Oct 5, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.